Literature DB >> 27538244

Contact Lens-Related Corneal Infections - United States, 2005-2015.

Jennifer R Cope, Sarah A Collier, Krithika Srinivasan, Erkinay Abliz, Ann Myers, Courtney J Millin, Andrew Miller, Michelle E Tarver.   

Abstract

Keratitis (inflammation of the cornea) can result from contact lens wear or other causes. Keratitis from all causes, including contact lens wear, results in approximately 1 million clinic and emergency department visits annually, with an estimated cost of $175 million in direct health care expenditures in 2010 (1). Approximately 41 million U.S. residents wear contact lenses, and in 2014, >99% of contact lens wearers surveyed reported at least one behavior that puts them at risk for a contact lens-related eye infection (2). The Center for Devices and Radiological Health at the Food and Drug Administration (FDA) regulates contact lenses as medical devices, and certain adverse events related to contact lenses are reported to FDA's Medical Device Report (MDR) database. To describe contact lens-related corneal infections reported to the FDA, 1,075 contact lens-related MDRs containing the terms "ulcer" or "keratitis" reported to FDA during 2005-2015 were analyzed. Among these 1,075 reports, 925 (86.0%) were reported by a contact lens manufacturer and 150 (14.0%) by an eye care provider or patient. Overall, 213 (19.8%) reports described a patient who had a central corneal scar, had a decrease in visual acuity, or required a corneal transplant following the event. Among the reports, 270 (25.1%) described modifiable factors known to be associated with an increased risk for contact lens-related corneal infections, including sleeping in contact lenses or poor contact lens hygiene; the remainder did not provide details that permitted determination of associated factors. Continued efforts to educate contact lens wearers about prevention of contact lens-related eye infections are needed.

Entities:  

Mesh:

Year:  2016        PMID: 27538244     DOI: 10.15585/mmwr.mm6532a2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  Topical Review: Contact Lens Eye Health and Safety Considerations in Government Policy Development.

Authors:  Carol Lakkis; Kathrine Osborn Lorenz; Michael Mayers
Journal:  Optom Vis Sci       Date:  2022-09-06       Impact factor: 2.106

2.  Complications Leading to Keratoplasty among Contact Lens Users and LASIK Patients: A 10-Year Cross-Sectional Analysis.

Authors:  Sloan W Rush; Blaze Bulla; Ryan B Rush
Journal:  J Ophthalmol       Date:  2021-08-13       Impact factor: 1.909

3.  American Academy of Optometry Microbial Keratitis Think Tank.

Authors:  Loretta B Szczotka-Flynn; Joseph P Shovlin; Cristina M Schnider; Barbara E Caffery; Eduardo C Alfonso; Nicole A Carnt; Robin L Chalmers; Sarah Collier; Deborah S Jacobs; Charlotte E Joslin; Abby R Kroken; Carol Lakkis; Eric Pearlman; Oliver D Schein; Fiona Stapleton; Elmer Tu; Mark D P Willcox
Journal:  Optom Vis Sci       Date:  2021-03-01       Impact factor: 2.106

4.  Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.

Authors:  Han Du; Sumant Puri; Andrew McCall; Hannah L Norris; Thomas Russo; Mira Edgerton
Journal:  Front Cell Infect Microbiol       Date:  2017-02-15       Impact factor: 5.293

5.  Prevalence, habits and outcomes of using contact lenses among medical students.

Authors:  Nahla Khamis Ibrahim; Hadeel Seraj; Raida Khan; Marwa Baabdullah; Lina Reda
Journal:  Pak J Med Sci       Date:  2018 Nov-Dec       Impact factor: 1.088

6.  Corneal Infections Associated with Sleeping in Contact Lenses - Six Cases, United States, 2016-2018.

Authors:  Jennifer R Cope; Nuadum Muriel Konne; Deborah S Jacobs; Deepinder K Dhaliwal; Michelle K Rhee; Jia Yin; Thomas L Steinemann
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-17       Impact factor: 17.586

Review 7.  Foundational concepts in the biology of bacterial keratitis.

Authors:  Lawson Ung; James Chodosh
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.